.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Fuji
Dow
Cipla
Boehringer Ingelheim
Julphar
McKinsey
Moodys
Fish and Richardson

Generated: June 29, 2017

DrugPatentWatch Database Preview

IOPAMIDOL-250 IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Iopamidol-250 In Plastic Container, and what generic Iopamidol-250 In Plastic Container alternatives are available?

Iopamidol-250 In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in IOPAMIDOL-250 IN PLASTIC CONTAINER is iopamidol. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iopamidol profile page.

Summary for Tradename: IOPAMIDOL-250 IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list25
Clinical Trials: see list1,768
Patent Applications: see list1,560
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IOPAMIDOL-250 IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
IOPAMIDOL-250 IN PLASTIC CONTAINER
iopamidol
INJECTABLE;INJECTION074636-002Dec 30, 1997DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Harvard Business School
QuintilesIMS
Merck
Fish and Richardson
Boehringer Ingelheim
AstraZeneca
Moodys
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot